University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Other Publications in Zoonotics and Wildlife
Disease

Wildlife Disease and Zoonotics

2005

Evaluation of Western blotting methods using samples with or
without sodium phosphotungstic acid precipitation for diagnosis
of scrapie and chronic wasting disease
Hongsheng Huang
Animal Diseases Research Institute

Jasmine Rendulich
Animal Diseases Research Institute

Dan Stevenson
Animal Diseases Research Institute

Katherine I. O'Rourke
U.S. Department of Agriculture, katherine.orourke@ars.usda.gov

Aru Balachandran
Animal Diseases Research Institute

Follow this and additional works at: https://digitalcommons.unl.edu/zoonoticspub
Part of the Veterinary Infectious Diseases Commons

Huang, Hongsheng; Rendulich, Jasmine; Stevenson, Dan; O'Rourke, Katherine I.; and Balachandran, Aru,
"Evaluation of Western blotting methods using samples with or without sodium phosphotungstic acid
precipitation for diagnosis of scrapie and chronic wasting disease" (2005). Other Publications in
Zoonotics and Wildlife Disease. 104.
https://digitalcommons.unl.edu/zoonoticspub/104

This Article is brought to you for free and open access by the Wildlife Disease and Zoonotics at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Other Publications in
Zoonotics and Wildlife Disease by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Article

Evaluation of Western blotting methods using samples with or without
sodium phosphotungstic acid precipitation for diagnosis of scrapie and
chronic wasting disease
Hongsheng Huang, Jasmine Rendulich, Dan Stevenson, Katherine O’Rourke, Aru Balachandran

Abstract
The purpose of this study was to enhance the sensitivity of the Western blot (WB) test for use as an alternative and confirmatory
method for the diagnosis of scrapie and chronic wasting disease (CWD) in Canada by comparing 2 sample preparation procedures: an abnormal prion protein (PrPSc) concentration procedure using sodium phosphotungstic acid (PTA) precipitation and
a procedure using crude sample without precipitation. A total of 100 cerebrum samples (52 sheep and 48 elk), including
66 negative (31 sheep, 35 elk) and 34 positive (21 scrapie and 13 CWD positive) samples diagnosed by using immunohistochemistry (IHC) on retropharyngeal lymph node (RPLN) and medulla oblongata at obex, were tested by using WB with the 2 sample
preparation procedures. The WB using non-PTA enriched sample (crude extract) detected, on average, only 71.7% (9 of 15, 60.0%
for scrapie, 5 of 6, 83.3% for CWD) of the samples that tested positive by using WB with PTA enriched samples. No case was
positive by WB using crude extract but negative by WB using PTA enriched sample. No false positive was found. Serial dilution
of PTA precipitated samples demonstrated that the technique increases the detection limit approximately 100 fold. Additionally,
the comparison of the WB and IHC on cerebrum from all the positive cases demonstrated that WB following PTA precipitation
and IHC had 100% agreement by detecting 6 positive for CWD on cerebrum; while IHC detected scrapie in only 14 out of
15 positive cerebrum samples by using WB following PTA precipitation. Phosphotungstic acid precipitation is therefore a useful
adjunct to WB analysis of scrapie and CWD and tissues.

Résumé
Afin d’augmenter la sensibilité de l’épreuve d’immunobuvardage (WB) pour utilisation comme méthode alternative et de confirmation pour
le diagnostic de la tremblante et de la maladie débilitante chronique (CWD) au Canada, deux méthodes de préparation des échantillons pour
l’épreuve de détection par WB, la concentration de protéine prion anormale (PrP Sc) par précipitation à l’aide de phosphotungstate de sodium
(PTA) et une méthode utilisant l’échantillon brut sans précipitation ont été comparées. Un total de 100 échantillons de cerveau (52 moutons
et 48 cerfs), incluant 66 négatifs (31 moutons et 35 cerfs) et 34 positifs (21 moutons avec de la tremblante et 13 cerfs positifs pour le CWD),
diagnostiqués par examen immunohistochimique (IHC) des ganglions rétro-pharyngiens (RPLN) et de la moëlle allongée à l’obex, ont été
testés à l’aide de la méthode WB en utilisant les deux modes de préparation des échantillons. L’épreuve WB effectuée sur les échantillons
préparés sans précipitation a permis de détecter, en moyenne, seulement 71,7 % (9 sur 15, 60,0 % pour la tremblante; 5 sur 6, 83,3 % pour
CWD) des échantillons qui se sont avérés positifs par WB lorsque la méthode de préparation PTA a été utilisée. En aucune circonstance un
échantillon positif par WB préparé sans précipitation s’est-il avéré négatif lorsque préparé par la méthode PTA. Aucun résultat faux positif
ne fut trouvé. Des dilutions sériées des échantillons précipités avec PTA ont permis de démontrer que cette méthode de préparation augmentait la limite de détection par un facteur de 100. De plus, lors de la comparaison de tous les résultats positifs par les méthodes WB et IHC,
l’épreuve WB, suite à la préparation PTA, et la méthode IHC avaient 100 % de concordance pour détecter des échantillons de cerveau positifs pour CWD; alors que pour les cas de tremblante l’épreuve IHC ne détecta que 14 des 15 échantillons de cerveau démontrés positifs par
WB suite à la préparation PTA. Ainsi, la précipitation avec PTA est un ajout utile pour l’analyse par WB d’échantillons provenant d’animaux
suspectés de tremblante et de CWD.
(Traduit par Docteur Serge Messier)

Introduction
Transmissible spongiform encephalopathies (TSEs) are a group of
fatal, degenerative neurological diseases, including scrapie in sheep
and goats; chronic wasting disease (CWD) in deer and elk; bovine

spongiform encephalopathy (BSE); and a heterogeneous group of
iatrogenic, sporadic, familial, and transmitted diseases in humans
(1). In Canada, scrapie was first diagnosed in a sheep imported from
Britain in 1938 and occurs at a very low level (2). Chronic wasting
disease was first diagnosed in Canada in 1996 (2).
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Table I. Immunohistochemical (IHC) results for retropharyngeal lymph node (RPLN), obex,
and cerebrum samples from elk and sheep exposed to chronic wasting disease (CWD)
and scrapie under farm conditions
Total number
Species
tested
Sheep
52a
Elk
48a
a
Number of animals tested

Number of
IHC negative
(RPLN and medulla)
31
35

The TSEs are characterized by vacuolation and loss of neurons in
the central nervous system, and by the accumulation of the disease
isoform (abnormal prion protein or PrPSc) of host encoded cellular
(normal) prion protein (PrPC) (1). Although the exact nature of the
causative agent for TSE is still controversial, PrPSc is associated with
the pathogenesis of the TSEs and copurifies with infectivity (1). It is
generally believed that PrPSc is at least a major component of the
causative agent for TSEs (1) and PrPSc is a reliable marker for TSE
diagnosis. To date, there is no single completely satisfactory diagnostic method for TSE. The diagnosis of TSE has been mainly based
on histopathological findings combined with the demonstration of
the PrPSc by immunohistochemistry (IHC), Western blotting (WB),
or scrapie-associated fibrils (SAF) by electron microscopy (EM) (3,4).
More recently, several immunoassays have been validated as rapid
screening tests for TSE (5–7). Of the methods mentioned above,
histopathology and IHC examinations are routinely used and considered “gold” standard methods. Histopathological lesions can
only be identified in the late stages of the incubation period (8),
although the disease can be diagnosed in early stages through the
detection of PrPSc in nervous tissue (3,4,6,7). The PrPSc are not distributed uniformly throughout the brains of infected animals. The
medulla, at the level of the obex, is the most reliable site for testing
in early cases of scrapie, BSE, and CWD (4,7,9–16). Therefore, immunodetection of PrPSc by IHC or WB in this region of the brain is
considered optimal for early detection of the disease, before the onset
of brain lesions or clinical disease (4,7,9–12,15). Further, immunodetection of PrPSc by WB and IHC and detection of SAF by EM are not
affected by autolysis (17–21), and thus are useful tools for confirming a diagnosis when histopathological examination is inconclusive
as a result of post-mortem autolysis or poor preservation. The WB
method can demonstrate a typical pattern of 3 bands including
diglycosylated (high molecular mass), monoglycosylated (medium
molecular mass), and unglycosylated (the lowest molecular mass)
components in a certain molecular weight range. Thus WB is a valuable confirmatory tool for tests such as immunoassays, which do not
show characteristic features of PrPSc. Validation studies in Europe
indicate that WB is useful as a diagnostic tool for clinically suspected
BSE and scrapie cases, as well as for rapid surveillance or screening
to detect subclinically infected animals (7,15,16).
The detection sensitivity of WB tests in published studies varies
due to differences in tissue preparation methods, animal species,
and tissue types used (12,16,22,23). In addition, WB analysis is limited by the quantity of sample that can be loaded onto gels for
electrophoresis. The sensitivity of the WB test can be improved by
pretreatments that concentrate PrPSc. An ultracentrifugation proce-
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RPLN
21
13

Number of IHC positive
Medulla
Cerebrum
20
14
13
6

dure has been commonly used and recommended by the international animal health organization, Office International Des Epizooties
(OIE) (3). More recently, sodium phosphotungstic acid (PTA) has
been shown to specifically precipitate PrPSc molecules (24). The PTA
precipitation of PrPSc from variant Creutzfeldt-Jakob disease (vCJD)
affected brains increases the sensitivity of WB analysis (23). However,
PTA precipitation procedure followed by WB has not been validated
for diagnosis of CWD and scrapie. The objective of the present study
was to compare the sensitivity of PTA-enriched samples and nonenriched samples through WB analysis in order to diagnose CWD
and scrapie.

Materials and methods
Samples
One hundred cases, including 52 from sheep (21 scrapie positive,
31 negative) and 48 from elk (13 CWD positive and 35 negative) from
different farms in Canada and diagnosed between 1999 and 2003,
were selected at random from archived tissues for analysis in this
study (Table I). These samples were submitted for diagnosis of
scrapie and CWD as part of the TSE control program in Canada or
collected from a research project involving natural scrapie infection.
All of the above cases had formalin-fixed medulla and retropharyngeal lymph node (RPLN) samples for diagnosis of scrapie and CWD
by IHC as described for sheep (25) and elk (12). In the IHC tests,
monoclonal antibodies (Mabs) F89/160.1.5 (26) and F99/97.6.1 (11)
(provided by Dr. K. O’Rourke, ADRU, ARS, USDA, Pullman,
Washington State, USA) were pooled (3 g/mL each final concentration) to test for scrapie and F99/97.6.1 alone (3 g/mL final concentration) was used to test for CWD. All of the positive cases used in
this study were found positive by IHC on RPLN, and some were
also positive on the medulla oblongata at the obex and even fewer
tested positive on cerebrum (Table I). For the positive cases used in
this study, no case tested positive in brain but negative on RPLN by
IHC. Due to availability of the samples, only samples of cerebrum
were used in the current study.
In this study, cases that were positive for scrapie or CWD were
defined based on positive results on RPLN by IHC. For the WB
assays in this study, frozen cerebrum samples from 31 sheep and
35 elk that tested negative by IHC on formalin-fixed obex and RPLN
were used as controls for WB (Table I). Among the above 66 negative
cases, cerebrum samples of 14 negative cases (9 sheep and 5 elk,
respectively), collected from the region adjacent to that used for WB,
were also tested by IHC for negative controls. The WB and IHC tests
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were conducted for all the positive cases using the adjacent region
of cerebrum samples, namely, one section of formalin-fixed for IHC
and one portion frozen for WB. All the frozen tissues were stored at
80°C for long term storage or at 20°C for immediate use.

Tissue preparation for WB
Tissues were prepared as described (27) with minor modifications.
Briefly, 0.2 to 0.25 g of tissues were homogenized with disposable
probes or with a cell disrupter (FastPrep Cell Disrupter; Qbiogene
SA, Carlsbad, California, USA), as described below. One milliliter
of lysis buffer containing 0.5% Nodinet P-40 (B56009-70; EM Science,
Darmstdt, Germany) and 0.5% sodium deoxycholate (102906; ICN
Biomedicals, Aurora, Ohio, USA, or B43035-24; EM Science), in
10 mM Tris buffer, pH 7.5, was added to obtain a homogenate containing approximately 20% (w/v) tissue. Approximately 1 gram of
Zirconia in the form of 1 mm (in diameter) microbeads (BioSpec
Products, Bartlesville, Oklahoma, USA) was added and vortexed for
1 min or homogenized using the cell disrupter (FastPrep Cell
Disrupter) at a speed setting of 6.5 for 45 s. The homogenate was
incubated at room temperature for 30 min, and either processed
immediately or stored at 20°C.
For PTA enriched sample preparation (12,23), 0.6 mL of the above
lysed 20% homogenate was treated with an equal volume of 4%
sarkosyl solution, consisting of 4% N-lauroyl sodium sarcosinate
(L-9150; Sigma Chemical Company, Oakville, Ontario) in phosphate
buffered saline solution (PBSS), pH 7.4, at 37°C for 10 min, followed
by DNAse I (100 g/mL) (D-5025; Sigma Chemical Company) treatment at 37°C for 30 min. Following centrifugation at 1538  g
(4000 rpm) for 10 min, 1 mL of the supernatant was incubated with
proteinase K (PK) (P-2308; Sigma Chemical Company) at a final
concentration of 50 g/mL at 50°C for 40 min to destroy PrPC. The
PrPC is soluble and susceptible to PK digestion, whereas PrPSc is
resistant thus distinguishing between normal and disease specific
isoforms of PrP. In addition, there are no antibodies currently available that can differentiate PrPC from PrPSc. After PK digestion,
Pefablock SC (1 429 868; Roche Diagnostics, Laval, Quebec) (2 mM
final concentration) was added to stop PK activity. The supernatant
was then incubated with 80 L of PTA (P-6395; Sigma Chemical
Company) (4%, w/v, in 170 mM MgCl, pH 7.4) at a final concentration of 0.3%, followed by centrifugation at 16 249  g (13 000 rpm)
for 30 min. The pellet was resuspended in 12 L water for testing or
stored at 20°C if not tested immediately.
For crude extract (non-PTA enriched) preparation, the homogenate
was diluted 1:1 with lysis buffer to produce a 10% homogenate. For
each sample, 12 L of this homogenate was treated with PK at a final
concentration of 50 g/mL at 50°C for 40 min. The PK activity
was stopped by Pefablock SC (2 mM final concentration) (27). A
2nd aliquot, 6 L of the above 10% homogenate, was further diluted
with an equal volume of sterile water and used as PK negative
control.

Gel electrophoresis and Western blotting
The WB analysis was based on the method described by Tuo et al
(27) with some modifications. Briefly, each sample (12 L) was mixed
with NuPAGE sample buffer (15 L) and reducing agent (3 L)
(Invitrogen, Burlington, Ontario), then heated to 100°C for 10 min
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followed by centrifugation at 16 249  g (13 000 rpm) for 5 min.
Twelve microliters of supernatant was electrophoresed (50 min,
200 volts) onto NuPAGE pre-cast 12% Bis-Tris buffered sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(Invitrogen) using MOPS running buffer (Invitrogen). Gels were then
electroblotted using semi-dry transfer apparatus (Bio-Rad,
Mississauga, Ontario) in transfer buffer containing 0.025 M Tris base,
0.15 M glycine, and 10% (v/v) methanol for 1.5 h at 15 volts onto
polyvinylidene fluoride (PVDF) membrane (Bio-Rad). The PVDF
membranes were fixed for 15 s in methanol, followed by either
complete air drying for 15 min or immediate incubation in blocking
buffer as below. The PVDF membrane was pre-wetted in methanol
and then rinsed in water and immediately incubated in blocking
buffer (5% non-fat milk in 20 mM Tris-HCL, pH 7.5, 137 mM NaCl,
0.2% Tween-20) for either 1 h at room temperature or overnight at
4°C. The membrane was incubated for 1 h at room temperature with
3.5 g per mL of monoclonal antibody F99/97.6.1 (either provided
by Dr. K. O’Rourke, or purchased from VMRD, Pullman, Washington
State, USA), which recognizes a conserved epitope on the ruminant
PrPC and PrPSc molecules (25) in WB and IHC assay. After washing
3 times (5 min for each) with TBS-T (20 mM Tris-HCL, pH 7.5,
137 mM NaCl, 0.2% Tween-20), the membrane was incubated with
goat anti-mouse polyclonal serum conjugated with horseradish
peroxidase (170-6510; Bio-Rad) diluted 1:3000 in blocking buffer.
After washing 5 times (5 min per wash) with TBS-T, the membrane
was incubated with chemiluminescent substrate, ECL Plus (RPN2132;
Amersham Biosciences, Baie d’Urfé, Québec), for 5 min, and chemiluminescent signals were visualized by exposing the membrane to
x-ray film (Kodak x-ray film; InterScience, Mississauga, Ontario).
The samples were declared positive if the characteristic banding
patterns of PK-resistant core of PrPSc were present.

Comparison of PrPSc enrichment by PTA versus
non-enrichment
To determine the degree of enrichment achieved with PTA
precipitation, dilutions (30%, 10%, and 1% v/v) of 2 PTAprecipitated samples in NuPAGE sample buffer were prepared
prior to gel electrophoresis and analyzed by WB. The WB profile seen with the PTA enriched samples was frequently dense
and without clearly defined bands, presumably due to excess
proteins. To confirm the presence of PrPSc, 5 such samples were
selected, serially diluted, and then tested to determine if the typical band pattern, namely 3 bands (diglycosylated, monoglycosylated, and unglycosylated bands) between 20 to 30 kDa, was
obtained.

Comparison of WB method using PTA enriched
samples or crude extracts with IHC
As mentioned above, scrapie or CWD positive cases were determined based on the positive results on RPLN by IHC examinations
for this study. All of the positive cases used in this study were
positive by IHC on RPLN, and some were positive on the medulla
oblongata at the obex with fewer positive numbers on cerebrum
(Table I). Based on the availability of the tissues, the WB assay results
were compared to IHC results for cerebrum samples of 21 scrapie
positive and 13 CWD positive animals only. Additional cerebrum
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Table II. Comparison of immunohistochemistry (IHC) and Western blot (WB) assay with
and without phosphotungstic acid (PTA)-enrichment for cerebrum samples from chronic
wasting disease (CWD) positive elk and scrapie positive sheep
Total number
WB positive using
Species
compareda
IHC positiveb
crude homogenatec
Sheep
21
14
9
Elk
13
6
5
a
PrPSc detected by IHC on retropharyngeal lymph node (RPLN)
b
PrPSc detected by IHC on formalin fixed cerebrum
c
Number of samples with positive findings by WB using crude homogenates
d
Number of samples with positive findings by WB following PTA precipitation

Figure 1. Effects of phosphotungstic acid (PTA) precipitation, dilution limit,
using cerebral sample from a scrapie positive case. Lane 1, crude extract
(PrPSc not detected); 2, original (100%) PTA precipitated sample; 3 to 5,
serially (30%, 10%, and 1%, respectively) diluted from the original PTA
enriched sample on lane 2.

samples from 9 scrapie-negative and 5 CWD-negative animals were
tested by both WB and IHC as controls.

Results
Distribution of PrPSc in RPLN, medulla at the level
of the obex, and cerebrum of sheep and elk, as
detected by IHC
Samples from 100 animals (52 sheep and 48 elk) were randomly
selected from archived tissue collected over the course of Canadian
scrapie and CWD control programs and research projects with
natural scrapie infection. Scrapie and CWD were diagnosed through
examination of the RPLN for deposits of PrPSc detectable by IHC.
Samples of medulla at the level of the obex were also analyzed from
each animal (Table I). Thirty-one sheep and 35 elk that had no evidence of PrPSc in any tissue were considered PrPSc negative for this
study. However, the animals were from farms with at least 1 positive
TSE case and may represent animals in the early stages of disease,
when PrPSc is undetectable with the current testing methods. Of the
21 scrapie positive sheep with IHC-positive RPLN, 20 had PrP Sc in
the medulla and 14 had PrPSc in the cerebrum by IHC (Table I).
Thirteen elk with IHC-positive RPLN also had positive medulla
samples; of these elk, only 6 had positive immunostaining in the
cerebrum.

Phosphotungstic acid enrichment of PrPSc
To compare the sensitivity of the WB using the PTA enrichment
procedure with that using the non-enrichment procedure, 2 samples
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WB positive
using PTAd
15
6

Figure 2. Detection of scrapie PrPSc by Western blot (WB) of crude homogenates and phosphotungstic acid (PTA) precipitated samples from sheep
sample 19 (lanes 1 to 3), sample 1 (lanes 4 to 6), sample 32 (lanes 7 to 9),
sample 31 (lanes 10 to 12), and sample 30 (lanes 13 to 15). Samples were
incubated without proteinase K (PK) (lanes 1, 4, 7, 10, 13), with PK as a
crude extract (lanes 2, 5, 8, 11, 14) or with PTA precipitation after PK digestion (lanes 3, 6, 9, 12, 15). MW markers (arrows) 30 kDa and 20 kDa shown
on left.

that were WB negative using the crude homogenate but positive
using PTA enrichment were prepared by PTA precipitation and
examined as the original PTA sample (100%) and diluted to 30%,
10%, and 1% of the starting volume before analysis. Strong signals
were observed with the 30% and 10% dilutions and a weak signal
in the 1% sample (Figure 1). Starting wet weight equivalents for these
samples were 0.6 mg per lane in the crude homogenate, 60 mg in the
100% PTA precipitate, 20 mg in the 30% dilution, 6 mg in the 10%
dilution, and 0.6 mg in the 1% dilution. The sample volume loaded
per lane on the gel for the PTA procedure was equivalent to approximately 60 mg wet brain tissue and 0.6 mg for non-enrichment
procedure. Namely, the PTA procedure uses 100-fold more sample
than that of the non-enrichment procedure. Therefore, it is estimated
that most of the PrPSc could be precipitated by PTA.

Comparison of WB using PTA enriched samples
with those of crude extracts
Of the 15 samples of sheep cerebrum that tested positive with WB
using PTA enrichment procedure, 9 (60.0%) were positive by WB
using crude homogenate (Table II). Representative data from
WB analysis of the sheep samples are shown in Figure 2. Samples 30
and 32 show the typical PrPSc banding pattern in crude homogenates
(Figure 2, lanes 8 and 14) with a large increase in the signal following
PTA precipitation (Figure 2, lanes 9 and 15). Sample 31 showed a
weak signal with the crude homogenate, which was improved by
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Figure 3. Demonstration of typical PrPSc band pattern by serial dilutions of
a phosphotungstic acid (PTA) enriched scrapie positive sample. Lane 1,
original (100%) PTA enriched sample; 2 to 4, PTA enriched, serially (50%,
25%, and 12.5%, respectively) diluted from the sample of lane 1. MW markers (arrows) 30 kDa and 20 kDa shown on left.

PTA precipitation (Figure 2, lanes 11 and 12). Sample 19 and
1 showed no signal with the crude homogenate (Figure 2, lanes 2
and 5), although PrPSc was detectable in both samples following PTA
precipitation (Figure 2, lanes 3 and 6). The PTA precipitation of
samples with large amounts of PrPSc resulted in a signal without a
clearly defined pattern of bands. Serial dilution of these samples
resolved the bands and the typical pattern of PrPSc could be demonstrated. Figure 3 shows 1 of 5 such diluted samples.
Of the 6 elk cerebrum samples that were positive for CWD by IHC
on paired fixed tissue, 5 were positive by using the crude homogenate without PTA precipitation (Table II, Figure 4). An additional
sample was positive following PTA precipitation (Figure 4, lane 5),
although the crude homogenate was negative (Figure 4, lane 6). No
signal was observed from PK treated samples that were negative by
IHC (Figure 4, lanes 2 and 3). Samples that were positive by using
crude extracts (sample 10, lane 9) showed an increased signal following PTA precipitation (lane 10).
For all scrapie and CWD cases, there was no case that was positive
by WB using crude extract but negative by WB using PTA enriched
sample. Meanwhile, there was a positive correlation between the
intensity of the PrPSc bands detected by non-enriched and PTAenriched positive samples; the more intense the bands detected by
PTA-enriched sample, the more intense the bands by non-enriched
method (Figures 2 and 4).

Comparison of the results of WB and IHC tests
The WB tests using both PTA enriched samples and crude extracts
were 100% specific; all 66 TSE-negative samples (31 sheep and
35 elk with no detectable PrPSc in RPLN and medulla at obex) were
negative by WB using either procedure (Table II). In addition,
14 negative samples (9 sheep and 5 elk), randomly selected from the
cerebral region as controls, were negative by both IHC and WB. The
sensitivity of WB using PTA enriched samples was 100% for CWD
(6/6 samples). The WB using PTA enrichment procedure detected
15 samples of cerebrum that were positive for scrapie, while IHC
identified 14 samples of cerebrum that were positive for scrapie;
namely, the WB following PTA precipitation identified one more
positive scrapie case when compared with IHC on cerebrum. For
this additional positive case, the brain stem was also positive by WB
with and without PTA enrichment and the obex was positive by IHC
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Figure 4. Detection of chronic wasting disease (CWD) PrPSc by Western
blot (WB) of crude homogenates and phosphotungstic acid (PTA) precipitated samples from negative control elk sample 25 (lanes 2 to 4), positive
sample 4 (lanes 5 to 7), and positive sample 7 (lanes 8 to 10), analyzed
after proteinase K (PK) digestion and PTA precipitation (lanes 2, 5, 8), as
crude homogenates (lanes 3, 6, 9) or without PK digestion or PTA precipitation (lanes 4, 7, 10). MW markers (arrows) 30 kDa and 20 kDa shown
on left.

(not shown). This case also showed band patterns similar to other
scrapie positive cases by WB (not shown). The sensitivity was lower
(64.3%, 9 of 14 for scrapie and 83.3%, 5 of 6 samples for CWD) for
non-PTA procedure when compared with IHC on cerebrum (Table II).

Discussion
Phosphotungstic acid enrichment has been applied to brain, tonsil, and muscle tissues in either WB or immunoassays in humans,
mice, sheep, deer, and elk (12,23,24,28–31). The objective of this study
was to compare the performance of 2 tissue preparation methods,
crude and PTA enrichment, for WB detection of PrPSc in brain tissue
from elk and sheep exposed to a TSE under field conditions.
Phosphotungstic acid precipitation increased the sensitivity of the
WB analysis for sheep and elk PrPSc approximately 100-fold, a finding similar to that reported for detection of human PrPSc from cases
of vCJD (23). The WB following PK digestion and PTA precipitation
of cerebrum tissue detected all of the positive cerebral samples of
the same animals as identified by IHC for both scrapie and CWD
cases. In addition, WB following PK digestion and PTA precipitation
detected one more scrapie positive cerebrum, which was negative
by IHC. No unusual findings, such as PrPSc distribution in various
brain sites or band patterns by WB, were observed in this case. The
reason for identification of this additional positive case, from a
sample of cerebrum by WB using PTA enrichment, is not clear. It
could be due to the higher sensitivity of this procedure than IHC.
Another reason could be the uneven distribution of the PrPSc in the
tissues (7,12,20). The WB, without PTA precipitation, showed a lower
sensitivity, 64.3% for sheep and 83.3% for elk, when compared with
IHC of cerebrum samples. The only tissue for which both frozen and
fixed samples were available for this comparison was cerebrum, a
region of the brain that is a less sensitive indicator of disease than
the medulla at the obex in sheep, cattle, deer, and elk, or the lymph
node in sheep, deer, and elk. Availability of paired tissues from
animals sampled in regulatory programs remains an obstacle to large
scale studies evaluating test methodologies based on fixed versus
frozen tissues.
The results from the current study demonstrate that WB with PTA
enrichment of cerebrum samples is a sensitive, specific, and practical method for analyzing the samples from late stage scrapie or
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CWD. This method would be valuable for autolyzed tissues or for
confirmation of IHC results. Paired samples from lymphoid tissue
and from the medulla at the level of the obex will be needed to
determine the diagnostic sensitivity of the WB test for preclinical
TSE in sheep, deer, and elk.
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